CPLM 1.0 - Compendium of Protein Lysine Modification
TagContent
CPLM ID CPLM-001990
UniProt Accession
Genbank Protein ID
Genbank Nucleotide ID
Protein Name
 Apolipoprotein E 
Protein Synonyms/Alias
 Apo-E 
Gene Name
 Apoe 
Gene Synonyms/Alias
  
Created Date
 July 27, 2013 
Organism
 Rattus norvegicus (Rat) 
NCBI Taxa ID
 10116 
Lysine Modification
Position
Peptide
Type
References
105ETRARLAKEVQAAQAubiquitination[1]
252QMEEVRSKMEEQTQQacetylation[2]
252QMEEVRSKMEEQTQQubiquitination[1]
Reference
 [1] Synaptic protein ubiquitination in rat brain revealed by antibody-based ubiquitome analysis.
 Na CH, Jones DR, Yang Y, Wang X, Xu Y, Peng J.
 J Proteome Res. 2012 Sep 7;11(9):4722-32. [PMID: 22871113]
 [2] Proteomic analysis of lysine acetylation sites in rat tissues reveals organ specificity and subcellular patterns.
 Lundby A, Lage K, Weinert BT, Bekker-Jensen DB, Secher A, Skovgaard T, Kelstrup CD, Dmytriyev A, Choudhary C, Lundby C, Olsen JV.
 Cell Rep. 2012 Aug 30;2(2):419-31. [PMID: 22902405
Functional Description
 Mediates the binding, internalization, and catabolism of lipoprotein particles. It can serve as a ligand for the LDL (apo B/E) receptor and for the specific apo-E receptor (chylomicron remnant) of hepatic tissues. 
Sequence Annotation
 REPEAT 72 93 1.
 REPEAT 94 115 2.
 REPEAT 116 137 3.
 REPEAT 138 159 4.
 REPEAT 160 181 5.
 REPEAT 182 203 6.
 REPEAT 204 225 7.
 REPEAT 226 247 8.
 REGION 72 247 8 X 22 AA approximate tandem repeats.
 REGION 150 160 LDL receptor binding (Potential).
 REGION 154 157 Heparin-binding (By similarity).
 REGION 221 228 Heparin-binding (By similarity).  
Keyword
 Chylomicron; Complete proteome; Direct protein sequencing; HDL; Heparin-binding; Lipid transport; Phosphoprotein; Reference proteome; Repeat; Secreted; Signal; Transport; VLDL. 
Sequence Source
 UniProt (SWISSPROT/TrEMBL); GenBank; EMBL 
Protein Length
 312 AA 
Protein Sequence
MKALWALLLV PLLTGCLAEG ELEVTDQLPG QSDQPWEQAL NRFWDYLRWV QTLSDQVQEE 60
LQSSQVTQEL TVLMEDTMTE VKAYKKELEE QLGPVAEETR ARLAKEVQAA QARLGADMED 120
LRNRLGQYRN EVNTMLGQST EELRSRLSTH LRKMRKRLMR DADDLQKRLA VYKAGAQEGA 180
ERGVSAIRER LGPLVEQGRQ RTANLGAGAA QPLRDRAQAL SDRIRGRLEE VGNQARDRLE 240
EVREQMEEVR SKMEEQTQQI RLQAEIFQAR IKGWFEPLVE DMQRQWANLM EKIQASVATN 300
SIASTTVPLE NQ 312 
Gene Ontology
 GO:0042627; C:chylomicron; IEA:UniProtKB-KW.
 GO:0030425; C:dendrite; IDA:RGD.
 GO:0005615; C:extracellular space; IDA:RGD.
 GO:0031232; C:extrinsic to external side of plasma membrane; IDA:RGD.
 GO:0005794; C:Golgi apparatus; IDA:RGD.
 GO:0034364; C:high-density lipoprotein particle; IEA:UniProtKB-KW.
 GO:0034363; C:intermediate-density lipoprotein particle; IEA:Compara.
 GO:0005770; C:late endosome; IDA:RGD.
 GO:0034362; C:low-density lipoprotein particle; IEA:Compara.
 GO:0043025; C:neuronal cell body; IDA:RGD.
 GO:0034361; C:very-low-density lipoprotein particle; IEA:UniProtKB-KW.
 GO:0016209; F:antioxidant activity; IEA:Compara.
 GO:0001540; F:beta-amyloid binding; ISS:UniProtKB.
 GO:0017127; F:cholesterol transporter activity; IEA:Compara.
 GO:0008201; F:heparin binding; IEA:UniProtKB-KW.
 GO:0046848; F:hydroxyapatite binding; IDA:RGD.
 GO:0005319; F:lipid transporter activity; IDA:RGD.
 GO:0071813; F:lipoprotein particle binding; IEA:Compara.
 GO:0046911; F:metal chelating activity; IEA:Compara.
 GO:0060228; F:phosphatidylcholine-sterol O-acyltransferase activator activity; IEA:Compara.
 GO:0005543; F:phospholipid binding; IDA:RGD.
 GO:0007568; P:aging; IDA:RGD.
 GO:0048844; P:artery morphogenesis; IEA:Compara.
 GO:0006874; P:cellular calcium ion homeostasis; IEA:Compara.
 GO:0071397; P:cellular response to cholesterol; IEP:RGD.
 GO:0071363; P:cellular response to growth factor stimulus; IEP:RGD.
 GO:0071347; P:cellular response to interleukin-1; IEP:RGD.
 GO:0019934; P:cGMP-mediated signaling; IEA:Compara.
 GO:0006707; P:cholesterol catabolic process; IEA:Compara.
 GO:0033344; P:cholesterol efflux; IEA:Compara.
 GO:0042632; P:cholesterol homeostasis; IEA:Compara.
 GO:0034382; P:chylomicron remnant clearance; IEA:Compara.
 GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:Compara.
 GO:0034380; P:high-density lipoprotein particle assembly; IEA:Compara.
 GO:0034384; P:high-density lipoprotein particle clearance; IEA:Compara.
 GO:0034375; P:high-density lipoprotein particle remodeling; IEA:Compara.
 GO:0006917; P:induction of apoptosis; IEA:Compara.
 GO:0042158; P:lipoprotein biosynthetic process; IEA:Compara.
 GO:0042159; P:lipoprotein catabolic process; IEA:Compara.
 GO:0042157; P:lipoprotein metabolic process; IDA:RGD.
 GO:0034374; P:low-density lipoprotein particle remodeling; IEA:Compara.
 GO:0051651; P:maintenance of location in cell; IEA:Compara.
 GO:0043537; P:negative regulation of blood vessel endothelial cell migration; IEA:Compara.
 GO:0045541; P:negative regulation of cholesterol biosynthetic process; IEA:Compara.
 GO:0001937; P:negative regulation of endothelial cell proliferation; IEA:Compara.
 GO:0050728; P:negative regulation of inflammatory response; IEA:Compara.
 GO:0043407; P:negative regulation of MAP kinase activity; IEA:Compara.
 GO:0043524; P:negative regulation of neuron apoptotic process; IDA:RGD.
 GO:0010544; P:negative regulation of platelet activation; IEA:Compara.
 GO:0007263; P:nitric oxide mediated signal transduction; IEA:Compara.
 GO:0048709; P:oligodendrocyte differentiation; IEP:RGD.
 GO:0014012; P:peripheral nervous system axon regeneration; IEP:RGD.
 GO:0033700; P:phospholipid efflux; IEA:Compara.
 GO:0045773; P:positive regulation of axon extension; IDA:RGD.
 GO:0030828; P:positive regulation of cGMP biosynthetic process; IEA:Compara.
 GO:0010875; P:positive regulation of cholesterol efflux; IEA:Compara.
 GO:0010873; P:positive regulation of cholesterol esterification; IEA:Compara.
 GO:0032805; P:positive regulation of low-density lipoprotein particle receptor catabolic process; IEA:Compara.
 GO:0051044; P:positive regulation of membrane protein ectodomain proteolysis; IEA:Compara.
 GO:0051000; P:positive regulation of nitric-oxide synthase activity; IEA:Compara.
 GO:0006898; P:receptor-mediated endocytosis; IEA:Compara.
 GO:0032489; P:regulation of Cdc42 protein signal transduction; IEA:Compara.
 GO:0010468; P:regulation of gene expression; IEA:Compara.
 GO:0002021; P:response to dietary excess; IEA:Compara.
 GO:0045471; P:response to ethanol; IEP:RGD.
 GO:0032868; P:response to insulin stimulus; IEP:RGD.
 GO:0006979; P:response to oxidative stress; IEA:Compara.
 GO:0032526; P:response to retinoic acid; IEP:RGD.
 GO:0043691; P:reverse cholesterol transport; IEA:Compara.
 GO:0006641; P:triglyceride metabolic process; IEA:Compara.
 GO:0042311; P:vasodilation; IEA:Compara.
 GO:0034447; P:very-low-density lipoprotein particle clearance; IEA:Compara.
 GO:0034372; P:very-low-density lipoprotein particle remodeling; IEA:Compara. 
Interpro
 IPR013326; ApoA.
 IPR000074; ApoA1_A4_E. 
Pfam
 PF01442; Apolipoprotein 
SMART
  
PROSITE
  
PRINTS